𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

✍ Scribed by Kunio Matsumoto; Toshikazu Nakamura


Book ID
108582266
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
1010 KB
Volume
94
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The HGF/SF antagonist NK4 reverses fibro
✍ Gaynor Davies; Malcolm D. Mason; Tracey A. Martin; Christian Parr; Gareth Watkin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 192 KB

## Abstract Our study examined the __in vitro__ and __in vivo__ responses of a newly discovered HGF/SF antagonist, NK4, on HGF/SF‐promoted growth of human prostate cancer cells (PC‐3). Nude mice were s.c. injected with either PC‐3‐ and/or HGF/SF‐producing fibroblasts (MRC5), and tumor size was meas

Nk4, a new HGF/SF variant, is an antagon
✍ Christian Parr; Steven Hiscox; Toshikazu Nakamura; Kunio Matsumoto; Wen G. Jiang πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 285 KB πŸ‘ 1 views

Hepatocyte Growth Factor/Scatter Factor (HGF/SF) is a heterodimeric molecule that plays a key role in the regulation of migration, invasion and angiogenesis in cancer, via activation of its receptor, c-met. HGF/SF is composed of an alpha-chain, containing the N-terminal hairpin domain and 4 kringle

Inhibition of Met/HGF receptor and angio
✍ Yoshinori Suzuki; Katsuya Sakai; Junko Ueki; Qing Xu; Takahiro Nakamura; Hideaki πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 707 KB

## Abstract NK4 exhibits two distinct biological actions: antagonistic inhibition of hepatocyte growth factor (HGF) through binding to the Met/HGF receptor, and antiangiogenic action through binding to perlecan. Here, the anti‐tumor effect of NK4 on malignant pleural mesothelioma was investigated.